CTRI/2014/07/004752Other未知
A RANDOMIZED, OPEN LABEL, TWO TREATMENT, TWO PERIOD, TWO SEQUENCE,SINGLE DOSE, CROSSOVER, COMPARATIVE PHARMACOKINETIC &PHARMACODYNAMIC STUDY OF SALMETEROL 25mg and FLUTICASONE PROPIONATE 250mgDRY POWDER INHALER (SUN DPI) OF SUN PHARMA ADVANCED RESEARCH COMPANYLIMITED, INDIA AND SERETIDETM ACCUHALERTM 50/500 (SALMETEROL 50mg andFLUTICASONE PROPIONATE 500mg) DRY POWDER INHALER OF GLAXOSMITHKLINE INMODERATE TO SEVERE ASTHMATIC PATIENTS.
试验速览
- 阶段
- 未知
- 状态
- Other
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Asthmatic subjects, 18 years of age or older
- •-Having no evidence of underlying disease (except asthma)
- •-Willing to sign the informed consent form
- •-Ability to use the dry powder inhaler correctly.
排除标准
- •-Having history of clinically significant gastrointestinal, dermatological, cardiovascular,
- •renal, hematological, psychiatric, cerebrovascular, neurological, hepatic, pulmonary
- •-Having hypersensitivity or allergy to ingredients of the IP
- •-Subjects determined by the study physician to have any medical condition that could jeopardize
- •their health or prejudice the results
- •-Females who are pregnant, breastfeeding, or are likely to become pregnant.
研究者
相似试验
暂停
不适用
To monitor the safety and to assess bioequivalence of Bortezomib for injection, 3.5 mg/vial (1.3 mg/m2 dose) of Sun Pharmaceutical Industries Limited and Velcade (Bortezomib) for injection 3.5 mg/vial (1.3 mg/m2 dose) of Millennium Pharmaceuticals, in multiple myeloma patients, under fed conditions.CTRI/2013/12/004235Sun Pharmaceutical Industries Ltd40
Unknown
1 期
Pharmacology study of brimonidineCTRI/2016/01/006491Sun Pharma Advanced Research Company Limited24
已完成
不适用
To monitor safety and assess bioequivalence of Leuprolide Acetate 7.5 mg Depot suspension of Sun Pharmaceutical Industries Limited,India and Lupron Depot 7.5 mg depot suspension of TAP Pharmaceutical Inc., USA under fasting conditions in prostatic carcinoma patients undergoing initial therapy.CTRI/2012/02/002436Sun Pharmaceutical Industries Ltd60
已完成
不适用
Study of baclofen in subjects with spasticityCTRI/2018/04/013139Sun Pharmaceuticals Industries Ltd
招募中
不适用
Comparative Bioavailability of Tegafur 20 mg, Gemiracil 5.8 mg, and Oteracil 15.8 mg capsule with Teysuno, (containing Tegafur 20 mg, Gemiracil 5.8 mg, and Oteracil 15.8 mg) capsule in human subjects with metastatic gastric cancer.CTRI/2021/01/030278BDR Pharmaceuticals Internationals Pvt Ltd